1. Home
  2. LEE vs HLVX Comparison

LEE vs HLVX Comparison

Compare LEE & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • HLVX
  • Stock Information
  • Founded
  • LEE 1890
  • HLVX 2020
  • Country
  • LEE United States
  • HLVX United States
  • Employees
  • LEE N/A
  • HLVX N/A
  • Industry
  • LEE Newspapers/Magazines
  • HLVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • HLVX Health Care
  • Exchange
  • LEE Nasdaq
  • HLVX Nasdaq
  • Market Cap
  • LEE 90.6M
  • HLVX 92.9M
  • IPO Year
  • LEE N/A
  • HLVX 2022
  • Fundamental
  • Price
  • LEE $11.46
  • HLVX $1.86
  • Analyst Decision
  • LEE
  • HLVX Hold
  • Analyst Count
  • LEE 0
  • HLVX 5
  • Target Price
  • LEE N/A
  • HLVX $2.33
  • AVG Volume (30 Days)
  • LEE 23.1K
  • HLVX 169.4K
  • Earning Date
  • LEE 02-06-2025
  • HLVX 03-19-2025
  • Dividend Yield
  • LEE N/A
  • HLVX N/A
  • EPS Growth
  • LEE N/A
  • HLVX N/A
  • EPS
  • LEE N/A
  • HLVX N/A
  • Revenue
  • LEE $600,264,000.00
  • HLVX N/A
  • Revenue This Year
  • LEE N/A
  • HLVX N/A
  • Revenue Next Year
  • LEE N/A
  • HLVX N/A
  • P/E Ratio
  • LEE N/A
  • HLVX N/A
  • Revenue Growth
  • LEE N/A
  • HLVX N/A
  • 52 Week Low
  • LEE $7.57
  • HLVX $1.55
  • 52 Week High
  • LEE $19.63
  • HLVX $20.22
  • Technical
  • Relative Strength Index (RSI)
  • LEE 32.32
  • HLVX 45.95
  • Support Level
  • LEE $11.40
  • HLVX $1.67
  • Resistance Level
  • LEE $13.69
  • HLVX $1.97
  • Average True Range (ATR)
  • LEE 0.80
  • HLVX 0.08
  • MACD
  • LEE -0.10
  • HLVX -0.01
  • Stochastic Oscillator
  • LEE 6.58
  • HLVX 51.91

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About HLVX HilleVax Inc.

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Share on Social Networks: